Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

The latest discovery in obesity medicine will be available in less invasive creams and patches, known as transdermal drug ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...